Marketing & Sales
help pharmaceuticals is active in the Greek market for over 40 years, with established Marketing & Sales functions.
help pharmaceuticals is active in the Greek market for over 40 years, with established Marketing & Sales functions.
The Marketing Department’s key goal, has been to establish help pharmaceuticals as a “Highly scientific pharmaceutical company, with top-quality medicinal products” for the Greek health care professionals & the patients.
The Marketing Department colleagues have accumulated substantial experience in the promotion of pharmaceuticals through the development of appropriate strategies, unique product campaigns and clinical research, both in Greece and Internationally.
The Marketing Department with the support of the Medical Department, the Greek University Medical Community and CRO organizations, has launched and supported major Clinical Trials over the years.
Due to the changes occurring in the Health Care Sector of Greece, the Sales Department has recently developed a network with the major wholesalers in Greece. Wholesalers are becoming a key player in the market, and this role is expected to be strengthened in the future.
In addition, The Sales Department covers diverse medical specialties and, lately, selected pharmacies nationwide. The team operates on international level Sales Force Management Techniques & Processes (targeting, segmentation, account planning, HR management, training etc) and values the skills of speed, flexibility and market awareness.
Clinical Trial 1 (Phase IV, EudraCT 2007-001947-23)
Title: “A multicenter, randomized, parallel patients’ group, comparative clinical trial for the assessment of efficacy and safety of Pelethrocin®/Help Pharmaceuticals 500 mg (generic diosmin & hesperidin MPFF) versus Daflon®/Servier 500 mg (original diosmin & hesperidin MPFF) in the treatment of chronic venous insufficiency patients (a therapeutic equivalence trial).”
Study Design: Prospective, multicenter, randomized, comparative therapeutic equivalence study with parallel patient groups.
Centers: 3 University Clinics in Athens & Patras
Clinical Trial 2 (Phase IIb, EudraCT 2007-003934-40)
Title: “A randomised, double-blind, placebo-controlled, parallel groups clinical trial for the evaluation of efficacy and safety of diclofenac sodium 3% administered topically in patients with actinic keratoses (AK).
Study Design: Prospective, randomised, double-blind, placebo-controlled, multicenter, parallel groups
Center: “Andreas Sygros” Dermatology Hospital, University of Athens
Clinical Trial 3 (Phase IIb, EudraCT 2006-006328-20)
Title: “Co-administration of L-carnitine with simvastatin reduces lipoprotein(a) levels compared with simvastatin monotherapy: a randomized, double-blind, placebo-controlled study”.
Study Design: randomized, double-blind, multicenter, placebo controlled clinical trial of parallel groups
Centers: 1 University Hospital Clinic and 3 National Health System Hospitals
